Stephanie Parker Palmer

Special Counsel

I can translate any business deal into a written agreement, but I also help clients structure and negotiate transactions to develop and commercialize innovative healthcare products.

Stephanie Palmer’s practice focuses on representing public and private life science companies in a wide range of commercial transactions, including technology licenses and acquisitions, research and development collaborations and distribution and manufacturing agreements.

Download full bio 


  • Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb 

  • Hansa Biopharma Announces Collaboration with Sarepta 

  • Therachon Sells to Pfizer for up to $810 Million 

  • Avidity Biosciences Licensing and Research Collaboration with Eli Lilly 





  • Washington College of Law American University
    JD, magna cum laude, 2012

  • University of Delaware
    BA, International Relations, Spanish and English
    cum laude, 2008

Admissions & Credentials

New York